A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors

Clinical trial NCT05036291 · TERMINATED

Trial details

NCT number: NCT05036291
Sponsor: Ningbo Newbay Technology Development Co., Ltd
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-10-01
Primary completion: 2025-09-24
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.